Sangamo Therapeutics (NASDAQ:SGMO) is scheduled to announce Q2 earnings results on Wednesday, August 7th, after market close.
The consensus EPS Estimate is -$0.34 and the consensus Revenue Estimate is $13.58M (-36.6% Y/Y).
Over the last 2 years, sgmo has beaten EPS estimates 63% of the time and has beaten revenue estimates 50% of the time.
Over the last 3 months, EPS estimates have seen 0 upward revisions and 4 downward. Revenue estimates have seen 0 upward revisions and 4 downward.
Subscribe for full text news in your inbox